Adverse Event Reporting
VAERS ID | 965209 |
---|---|
Gender | Male |
Age | 62 |
StateCode | |
Pharmaceutical Company | PFIZER\BIONTECH |
Lot Number | |
Number of vaccinations | |
Vaccinated | 2021-01-11 |
Onset | 2021-01-14 |
Condition | Hospitalized Life Threatening Permanent Disability Recovered |
Symptoms
- Acute myocardial infarction
- Echocardiogram abnormal
- Coronary artery occlusion
- Ejection fraction decreased
- Ventricular hypokinesia
- Coronary arterial stent insertion
- Coronary artery stenosis
- Percutaneous coronary intervention
- Wall motion score index abnormal
Current Illness
None noted
Preexisting Conditions
Hypertension, prediabetes
Other Medications
Candesartan 4mg daily
Previous Vaccinations
Allergies
None
Laboratory Data
PCI on 1/14.
Acute subtotal occlusion of proximal LAD and severe diffuse disease extending to distal LAD.
Two DES to LAD (99% occluded) but RCA 50% and OMI1 60-65% also stenosed.
Echo cardiogram 1/15.
Pt noted to have severe wall motion abnormalities (severe hypokinesis of anterolateral and anteroseptal wall; akinesis of mid to distal anterior wall extending to the apex and distal inferior wall ) on echo.
EF 30-35%.
Received life vest on discharge.
Write-up
Pt admitted with a STEMI three days after vaccination with pzifer COVID-19 vaccine.
Short time (<2hr) between symptoms onset and medical care.
PCI on 1/14.
Acute subtotal occlusion of proximal LAD and severe diffuse disease extending to distal LAD.
Two DES to LAD (99% occluded) but RCA 50% and OMI1 60-65% also stenosed.
Echo cardiogram 1/15.
Pt noted to have severe wall motion abnormalities (severe hypokinesis of anterolateral and anteroseptal wall; akinesis of mid to distal anterior wall extending to the apex and distal inferior wall ) on echo.
EF 30-35%.
Received life vest on discharge.